Integrating oncology advanced practice providers and clinical pharmacists into clinical cancer research

Area of Science:

• Oncology
• Clinical Research
• Healthcare Policy

Background:

• Advanced Practice Providers (APPs), including Advanced Practice Registered Nurses, Physician Assistants, and Clinical Pharmacists (CPs), are integral to patient-centered cancer care in the U.S.
• Despite their prevalence, APPs are underrepresented in cancer clinical trials, limiting patient access and trial participation.
• Low participation in clinical trials hinders advancements in oncology care.

Purpose of the Study:

• To address the underutilization of APPs in cancer clinical research.
• To identify barriers hindering APP involvement in clinical trials.
• To propose solutions and resources for greater APP engagement in oncology research.

Main Methods:

• This position paper synthesizes insights from five professional oncology societies.
• It identifies key barriers to APP participation in clinical research.
• It outlines actionable strategies and resources to overcome these barriers.

Main Results:

• Identified barriers include educational gaps, unclear role expectations, insufficient protected time, restrictive policies, and inadequate financial support.
• Under-recognition of APP contributions also limits their research involvement.
• Solutions focus on enhancing education, clarifying roles, allocating protected time, and policy reform.

Conclusions:

• Meaningful engagement of APPs and CPs in oncology clinical research is imperative for advancing cancer care.
• Integrating APPs more fully will improve trial access, enhance patient outcomes, and reduce health inequities.
• Addressing identified barriers is essential for accelerating innovation in oncology research and care delivery.